当前位置: 首页 > 期刊 > 《中国医药科学》 > 2014年第20期
编号:13123208
盐酸羟考酮缓释片治疗中重度癌痛的临床观察(1)
http://www.100md.com 2014年10月15日 《中国医药科学》 2014年第20期
     [摘要]目的 观察盐酸羟考酮缓释片通过剂量滴定治疗中重度癌性疼痛的疗效及不良反应。 方法 78例中重度癌性疼痛患者,用剂量滴定的方法使用盐酸羟考酮缓释片进行止痛治疗。根据疼痛缓解程度调整剂量。连续用药至少2周,同时进行止痛效果、生活质量及不良反应的观察。 结果 经剂量滴定后78例中重度癌性疼痛患者口服盐酸羟考酮缓释片剂量范围10~160mg/次,q12h。患者中疼痛完全缓解24例(30.77%),部分缓解52例(66.67%),总的疼痛缓解率(CR+PR)为97.44%;中度疼痛缓解率为100.00%,重度疼痛缓解率为90.48%;患者生活质量明显提高,不良反应较少。主要不良反应为便秘,其次为恶心、呕吐、头晕等。结论 盐酸羟考酮缓释片通过剂量滴定的方法,可有效控制中重度癌性疼痛,不良反应较少,能显著地改善癌痛患者的生活质量。

    [关键词]盐酸羟考酮缓释片;癌性疼痛;疗效;不良反应;生活质量

    [中图分类号]R730.5 [文献标识码]B [文章编号]2095-0616(2014)20-61-04

    Clinical observatin of oxycodone in the treatment of 78 cases with moderate and severe cancer pain

    LI Juan1 WANG Juan1 LU Binbin1 WANG Jirong1 WANG Keming1 WANG Zhaoxia1 LU Xieqin2

    1.Department of Oncology, the Second Affiliated Hospital of Nanjing Medical University, Nanjing 210011, China; 2.Department of Pharmacy, the Second Affiliated Hospital of Nanjing Medical University, Nanjing 210011, China

    [Abstract]Objective To observe the analgesic effect and adverse effects of Oxycontin(Oxycodone Hydrochloride Controlled-release Tablets) with dose titration therapy on moderate and severe chronic cancer pain. Methods A total of 78 patients with moderate and severe chronic cancer pain were selected to be treated with Oxycontin. Oxycontin with dose titration therapy was administered at initial dose of 10mg every 12 hours, and was titrated upwards according to the extend of pain relief.All patients were treated for at least 2 weeks,simultaneously the analgesic effect, adverse effects and quality of life was investigated. Results Among the 78 patients suffering moderate and severe chronic cancer pain,The doses ranged between 10mg/to 160mg/12h. 24(30.77%) achieved complete remission, 52(66.67%) achieved partial remission, Total pain relief was 97.44%, and it was 100.00% in patients with moderate chronic cancer pain, 90.48% in patients with severe chronic cancer pain. The quality of life was significantly improved after the treatment with mild adverse effect.The main adverse effects were constipation,nausea and vomiting, and dizziness. Conclusion With dose titration therapy, Oxycodone are effective in controlling moderate and severe chronic cancer pain, and mproved the quality of life of patients significantly with mild adverse effect.

    [Key words]Oxycodone; Cancer Pain; AnalgesicEffect; Adverse Effects; Quality of Life

    疼痛是癌症患者最常见的临床症状之一,严重影响着患者的生活质量。世界卫生组织(world health organization,WHO) 把癌痛控制作为癌症控制的4个重点项目之一。世界疼痛大会也将疼痛列为第五生命体征。盐酸羟考酮缓释片是一种新型的半合成纯阿片受体激动剂,对中重度癌性疼痛疗效确切,不良反应少[1]。本研究收集应用盐酸羟考酮缓释片剂量滴定治疗中重度癌性疼痛患者共78例,对其止痛效果及不良反应等进行了观察及分析。, 百拇医药(李娟 王娟 陆彬彬 王继荣 王科明 王朝霞 卢协勤)
1 2 3下一页